{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:00:34Z","timestamp":1764079234726},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Technology of P.R. China","award":["2015RA4002"],"award-info":[{"award-number":["2015RA4002"]}]},{"name":"Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education","award":["<2009> No. 98"],"award-info":[{"award-number":["<2009> No. 98"]}]},{"name":"Innovative Research Team in University","award":["PCSIRT, IRT1270"],"award-info":[{"award-number":["PCSIRT, IRT1270"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573992","81403239","81220108027"],"award-info":[{"award-number":["81573992","81403239","81220108027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Longhua Medical Innovation Team Program","award":["LYCX-01"],"award-info":[{"award-number":["LYCX-01"]}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["2017-310"],"award-info":[{"award-number":["2017-310"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bone.2017.01.029","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T08:03:44Z","timestamp":1485245024000},"page":"222-232","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Differential response of bone and kidney to ACEI in db\/db mice: A potential effect of captopril on accelerating bone loss"],"prefix":"10.1016","volume":"97","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Nan","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Luan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Hui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Sau","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.01.029_bb0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mehy.2011.04.004","article-title":"The effect of renin angiotensin system on tamoxifen resistance","volume":"77","author":"Namazi","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bone.2017.01.029_bb0010","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3390\/jcm4111908","article-title":"Renin-angiotensin-aldosterone system blockade in diabetic nephropathy. Present evidences","volume":"4","author":"Lozano-Maneiro","year":"2015","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2017.01.029_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2014.00023","article-title":"Tissue renin-angiotensin systems: a unifying hypothesis of metabolic disease","volume":"5","author":"Skov","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bone.2017.01.029_bb0020","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1073\/pnas.0803751105","article-title":"Combination therapy with AT1 receptor blocker and vitamin D analog markedly ameliorates diabetic nephropathy","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.01.029_bb0025","first-page":"F791","article-title":"Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist","volume":"297","author":"Zhang","year":"2009","journal-title":"Am. J. Phys. Renal Phys."},{"key":"10.1016\/j.bone.2017.01.029_bb0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00125-009-1619-x","article-title":"Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes","volume":"53","author":"Ko\u00eftka","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2017.01.029_bb0035","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1097\/HJH.0b013e32834bbb4d","article-title":"Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition","volume":"29","author":"Inaba","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bone.2017.01.029_bb0040","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.biochi.2012.12.016","article-title":"Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT(1) receptor in osteoblasts","volume":"95","author":"Nakai","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.bone.2017.01.029_bb0045","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1074\/jbc.M807610200","article-title":"Angiotensin II type 2 receptor blockade increases bone mass","volume":"284","author":"Izu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.01.029_bb0050","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","article-title":"Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin system","volume":"159","author":"Garcia","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bone.2017.01.029_bb0055","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","article-title":"Use of beta-blockers and risk of fractures","volume":"292","author":"Schlienger","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2017.01.029_bb0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0895-7061(03)00845-8","article-title":"Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms","volume":"16","author":"P\u00e9rez-Castrill\u00f3n","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bone.2017.01.029_bb0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","article-title":"Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese","volume":"38","author":"Lynn","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.01.029_bb0070","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1157\/13095095","article-title":"Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril","volume":"127","author":"Garc\u00eda-Testal","year":"2006","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.bone.2017.01.029_bb0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study","volume":"24","author":"Rejnmark","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bone.2017.01.029_bb0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12020-014-0167-4","article-title":"Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis","volume":"46","author":"Ghosh","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.bone.2017.01.029_bb0085","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","article-title":"Risk of fractures in older adults using antihypertensive medications","volume":"26","author":"Solomon","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.01.029_bb0090","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-011-1831-7","article-title":"Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?","volume":"23","author":"Kwok","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.01.029_bb0095","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00774-012-0363-3","article-title":"The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese","volume":"30","author":"Zhang","year":"2012","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2017.01.029_bb0100","first-page":"17","article-title":"Effect of angiotensin converting enzyme inhibitor and benzodiazepine intake on bone loss in older Japanese","volume":"57","author":"Masunari","year":"2008","journal-title":"Hiroshima J. Med. Sci."},{"key":"10.1016\/j.bone.2017.01.029_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bone.2017.01.029_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4239\/wjd.v4.i4.101","article-title":"Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures","volume":"4","author":"Roy","year":"2013","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bone.2017.01.029_bb0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/1470320312471229","article-title":"Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin","volume":"15","author":"Zhang","year":"2014","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.bone.2017.01.029_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00774-013-0500-7","article-title":"Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes","volume":"32","author":"Diao","year":"2014","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2017.01.029_bb0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4236\/jdm.2012.23055","article-title":"Inhibition of renin activity by aliskiren ameliorates diabetic nephropathy in type 1 diabetes mouse model","volume":"2","author":"Zhang","year":"2012","journal-title":"J. Diabetes Mellitus"},{"key":"10.1016\/j.bone.2017.01.029_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ki.5002572","article-title":"Renoprotective role of the vitamin D receptor in diabetic nephropathy","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2017.01.029_bb0135","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00198-010-1404-1","article-title":"Alteration of vitamin D metabolic enzyme expression and calcium transporters abundance in kidney involved in type 1 diabetes-induced bone loss","volume":"22","author":"Zhang","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.01.029_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bone.2008.09.003","article-title":"Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet","volume":"44","author":"Zhang","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.01.029_bb0145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","article-title":"High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group","volume":"354","author":"Cappuccio","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2017.01.029_bb0150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bone.2017.01.029_bb0155","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1359\/jbmr.070510","article-title":"Osteoporosis in patients with diabetes mellitus","volume":"22","author":"Hofbauer","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.01.029_bb0160","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2009080872","article-title":"Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system","volume":"21","author":"Zhang","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.01.029_bb0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pharep.2013.09.010","article-title":"The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats","volume":"66","author":"Ert\u00fcrk\u00fcner","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bone.2017.01.029_bb0170","first-page":"11470","article-title":"Effect of fosinopril on chemerin and VEGF expression in diabetic nephropathy rats","volume":"8","author":"Huang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bone.2017.01.029_bb0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jdi.12004","article-title":"Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy","volume":"4","author":"Nakamura","year":"2013","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.bone.2017.01.029_bb0180","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/0886022X.2015.1012995","article-title":"Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy","volume":"37","author":"Ren","year":"2015","journal-title":"Ren. Fail."},{"key":"10.1016\/j.bone.2017.01.029_bb0185","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4103\/0366-6999.176987","article-title":"Renoprotective effect of the combination of renin-angiotensin system inhibitor and calcium channel blocker in patients with hypertension and chronic kidney disease","volume":"129","author":"Huang","year":"2016","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bone.2017.01.029_bb0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1359\/jbmr.081006","article-title":"Activation of renin-angiotensin system induces osteoporosis independently of hypertension","volume":"24","author":"Asaba","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.01.029_bb0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00774-010-0209-9","article-title":"Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts","volume":"29","author":"Liu","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2017.01.029_bb0200","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1248\/bpb.b14-00829","article-title":"Involvement of renin-angiotensin system in damage of angiotensin-converting enzyme inhibitor captopril on bone of normal mice","volume":"38","author":"Liu","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bone.2017.01.029_bb0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.33549\/physiolres.9300102","article-title":"Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats","volume":"50","author":"Broul\u00edk","year":"2001","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bone.2017.01.029_bb0210","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1097\/00004872-199512010-00065","article-title":"Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17beta-estradiol and their combination on the ovariectomy-induced cancellous bone loss in young rats","volume":"13","author":"Stimpel","year":"1995","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bone.2017.01.029_bb0215","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/jcp.24668","article-title":"Bradykinin regulates osteoblast differentiation by Akt\/ERK\/NF\u03baB signaling axis","volume":"229","author":"Srivastava","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2017.01.029_bb0220","first-page":"12584","article-title":"Captopril, an angiotensin-converting enzyme inhibitor, possesses chondroprotective efficacy in a rat model of osteoarthritis through suppression local renin-angiotensin system","volume":"8","author":"Tang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bone.2017.01.029_bb0225","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/sj.ki.5001624","article-title":"Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy","volume":"70","author":"Wang","year":"2006","journal-title":"Kidney Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217300297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217300297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T01:01:23Z","timestamp":1719018083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217300297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":45,"alternative-id":["S8756328217300297"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.01.029","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential response of bone and kidney to ACEI in db\/db mice: A potential effect of captopril on accelerating bone loss","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}